bupropion and citalopram

bupropion has been researched along with citalopram in 117 studies

Research

Studies (117)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (1.71)	18.7374
1990's	2 (1.71)	18.2507
2000's	36 (30.77)	29.6817
2010's	70 (59.83)	24.3611
2020's	7 (5.98)	2.80

Authors

Authors	Studies
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Ahman, M; Holmén, AG; Wan, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Glen, RC; Lowe, R; Mitchell, JB	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ostrow, D	1
Golden, RN; Potter, WZ; Rudorfer, MV	1
Leonard, BE	1
Anand, VS; Dewan, MJ	1
Fava, M; Rush, AJ; Trivedi, M	1
Bourin, M; Dailly, E; David, DJ; Hascoët, M; Ripoll, N	1
Hossie, H; Lam, RW; Solomons, K; Yatham, LN	1
Andersen, MP; Hogg, S; Pouzet, B	1
Cherng, CF; Hsiao, SY; Yang, YK; Yeh, TL; Yu, L	1
Biggs, MM; Fava, M; Lebowitz, BD; Luther, JF; Nierenberg, AA; Quitkin, F; Ritz, L; Rush, AJ; Shores-Wilson, K; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Akarsu, ES; Ayhan, IH; Cankurtaran, ES; Cekic, T; Ozalp, E; Palaoglu, O; Soygur, H; Turhan, L	1
Csoka, AB; Shipko, S	1
Williams, SC	1
Alpert, JE; Biggs, M; Fava, M; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Clayton, AH; Croft, HA; Horrigan, JP; Krishen, A; Modell, JG; Richard, NE; Wightman, DS	1
Selby, P	1
Bateman, ND; Buchanan, D; Clark, RC; Cuthbert, M; Kerr, S; Maxwell, SR; Steinke, D; Webb, DJ	1
Becker, ME; Beckham, JC; Bukenya, DS; Dennis, MF; Hertzberg, MA; Moore, SD	1
Biggs, MM; Fava, M; Friedman, ES; Hollon, SD; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Rush, AJ; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Brown, ES; Khan, DA; Rush, AJ; Vornik, LA	1
Shelton, RC	1
Nikiforuk, A; Wesołowska, A	1
Bystritsky, A; Feusner, JD; Kerwin, L; Vapnik, T	1
Curran, MP; Dhillon, S; Yang, LP	1
Eller, T; Maron, E; Shlik, J; Vasar, V	1
Balasubramani, GK; Kornstein, SG; Lesser, IM; Nierenberg, AA; Preskorn, SH; Rush, AJ; Shores-Wilson, K; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR; Young, EA	1
Davis, LL; Fava, M; Luther, JF; Nierenberg, AA; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR	1
Blier, P; El Mansari, M; Ghanbari, R	1
Fava, M; Gaynes, BN; Lesser, IM; Leuchter, AF; Luther, JF; Morris, DW; Perales, M; Rush, AJ; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR	1
Cho, JH; Choo, CS; Kang, SG; Lee, HJ; Park, YM	1
Carney, RM; Freedland, KE	1
Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR	1
Shader, RI	1
Eller, T; Maron, E; Nutt, DJ; Vasar, V	1
Burgoyne, KS; Cook, IA; Fava, M; Gilmer, WS; Greenwald, S; Howland, RH; Iosifescu, D; Jain, R; Leuchter, AF; Marangell, LB; Trivedi, MH; Zisook, S	1
Deliyannides, RA; McGrath, PJ; Quitkin, FM; Stewart, JW	1
Fava, M; Gaynes, BN; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR	1
Laje, G; McMahon, FJ; Perlis, RH; Rush, AJ	1
Brigham, EP; Chisolm, MS; Jones, HE; Strain, EC; Tuten, M	1
Katiyar, S; Kukade, G; Mahesh, R; Pandey, DK; Rudra, A; Viyogi, S	1
Leelahanaj, T	1
Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR	1
Bajo, E; Bigelli, M; De Ronchi, D; Olgiati, P; Serretti, A	1
Bobo, WV; Chen, H; Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR	1
Davis, LL; Fava, M; Friedman, ES; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S	1
Aberg, K; Adkins, DE; Clark, SL; Hettema, JM; McClay, JL; Souza, RP; van den Oord, EJ	1
Fava, M; Kallenberg, G; Lebowitz, B; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S	1
Bech, P; Fava, M; Rush, AJ; Trivedi, MH; Wisniewski, SR	1
Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T	1
Bodnik, D; Dannon, P; Kotler, M; Rosenberg, O; Shoenfeld, N	1
Balasubramani, GK; Davis, LL; Fava, M; Gaynes, BN; Howland, RH; Pilkinton, P; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S	1
Kiang, C; Lung, D; Yeh, K	1
Fava, M; Haley, CL; Kurian, BT; Morris, DW; Nierenberg, AA; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR	1
Capello, E; Krueger, F; Mancardi, G; Pardini, M; Uccelli, A	1
Bahk, WM; Jun, TY; Jung, YE; Song, HR; Wang, HR; Woo, YS	1
Fava, M; Perlis, RH; Perroud, N; Uher, R	1
Shahani, L	1
Balasubramani, GK; Kurian, B; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S	1
Burgoyne, KS; Cook, IA; Gilmer, WS; Greenwald, S; Howland, RH; Hunter, AM; Iosifescu, DV; Jain, R; Leuchter, AF; Trivedi, MH; Zisook, S	1
Młyniec, K; Nowak, G	2
Balasubramani, GK; Daly, E; Gaynes, BN; Kurian, BT; Lesser, I; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR	1
Blier, P; Blondeau, C; De Somma, E; Fusee, W; Jaworska, N; Knott, V; Norris, S; Smith, D; Tessier, P	1
Cadeddu, R; Carboni, E; Ibba, M; Sadile, A	1
Hsueh, JH; Huang, CC; Lu, YY; Wei, IH	1
Anagnostaras, SG; Carmack, SA; Howell, KK; Rasaei, K; Reas, ET	1
Amat, J; Bergeron, R; Blier, P; Blondeau, C; Chen, Y; Deliyannides, DA; Hellerstein, D; Laberge, L; McGrath, PJ; Norris, S; O'Shea, D; Pilowsky, DJ; Stewart, JW; Tessier, P; Withers, A	1
Blier, P; Blondeau, C; Fusee, W; Jaworska, N; Knott, V; Norris, S; Tessier, P	1
Carmody, T; Kurian, KR; Lesser, I; Morris, D; Myers, A; Rush, AJ; Toups, M; Trivedi, MH; Warden, D; Zisook, S	1
Blumenthal, SR; Castro, VM; Churchill, SE; Clements, CC; Erb, JL; Fava, M; Kohane, IS; Murphy, SN; Perlis, RH; Rosenfield, HR; Smoller, JW; Weilburg, JB	1
Abraham, K; Alschuler, D; Alvarenga, JE; Bruder, GE; Hellerstein, DJ; Keilp, JG; McGrath, PJ; Stewart, JW	1
Clarke, W; Jannetto, PJ; Johnson-Davis, KL; Langman, LJ; Marzinke, MA; Moskowitz, J; Petrides, AK	1
Cyriac, A; Kennedy, SH; Manierka, MS; McIntyre, RS; Ravindran, LN; Soczynska, JK; Styra, R	1
Abd El-Aty, AM; Cha, B; Cho, YA; El-Banna, HA; Hacımüftüoğlu, A; Jin, JS; Kim, GS; Lee, SJ; Park, CS; Park, S; Shim, JH; Shin, SC; Song, Y; Yu, EA	1
Amat, JA; Blier, P; Gerra, ML; Hellerstein, DJ; Marchesi, C; Stewart, JW	1
Krakowska, A; Mlyniec, K; Nowak, G; Opoka, W; Ostachowicz, B; Reczynski, W	1
Luther, JF; Rush, AJ; Sung, SC; Trivedi, MH; Wisniewski, SR	1
Batten, LA; Blier, P; Flament, MF; Hernandez, M; McGrath, P; Pilowsky, DJ; Poh, E; Stewart, JA; Stewart, JW; Weissman, MM; Wickramaratne, P	1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N	1
Coiro, MJ	1
Balasubramanian, T; Ferraro, A; Wiggins, A	1
Choi, TY; Han, DH; Kim, TH; Lee, H; Lee, YS; Park, JH; Roh, S; Son, JH; Song, J	1
Brooks, MM; Luther, JF; Potter, MA; Roberts, MS; Singh, A; Voorhees, RE; Wisniewski, SR	1
Drevets, WC; Li, QS; Narayan, VA; Seabrook, GR; Tian, C	1
Gadad, BS; Grannemann, B; Greer, T; Jha, MK; Mayes, TL; Minhajuddin, A; Rush, AJ; Soyombo, A; Trivedi, MH	1
Chekroud, AM; Gueorguieva, R; Krumholz, HM; Krystal, JH; McCarthy, G; Trivedi, MH	1
Chang, CC; Chang, HA; Chang, TC; Chao, PC; Chu, CW; Lin, PY; Liu, YW	1
Gadad, BS; Greer, TL; Jha, MK; Mayes, TL; Minhajuddin, A; Trivedi, MH	1
Dronamraju, N; Greer, TL; Jha, MK; Minhajuddin, A; Trivedi, MH; Wakhlu, S	1
Bloch, MH; Olten, B; Telang, S; Walton, C	1
Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A	1
Finkelstein, Y; Gomes, T; Juurlink, DN; Li, P; Macdonald, EM; Mamdani, MM	1
Grannemann, BD; Jha, MK; Malchow, AL; Rush, AJ; Trivedi, MH	1
Camsari, DD; Croarkin, PE; Daskalakis, ZJ; Gresbrink, MA; Lewis, CP; Nandakumar, AL; Sonmez, AI	1
Carmody, TJ; De La Garza, N; Grannemann, BD; Killian, MO; Rush, AJ; Trivedi, MH	1
Hong, Y; Joo, YH; Lee, JS; Shon, SH; Yoon, W	1
Alexander, KS; Miller, LL; Patton, TB; Rodriguez, TR; Sarfo, AN	1
Cipriani, A; Furukawa, TA; Ikeda, K; Imai, H; Maruo, K; Noma, H; Shinohara, K; Tanaka, S; Yamawaki, S	1
Jha, MK; Minhajuddin, A; Rush, AJ; South, C; Trivedi, MH	1
Huang, M; Lindau, M; Rathore, SS	1
Hu, J; Li, H; Li, Y; Shen, Y; Tan, Y; Wang, Z; Xu, X; Yu, Y; Zhang, H; Zhao, Q; Zhong, J	1
Blier, P; de la Salle, S; Jaworska, N; Knott, V; Smith, D	1
Hanna, K; Hatch, L; Herr, J; Sephien, A	1
Haas, DM; Marks, C; Quinney, SK; Silvola, R; Teal, E	1
Baugh, TB; Carr, CN; Reed, E; Sochacki, M; Straley, CM	1
Camino, S; Godoy, A; Smith, J; Strejilevich, SA; Szmulewicz, A	1
Ebrahimi-Ghiri, M; Khakpai, F; Mohammadi-Mahdiabadi-Hasani, MH; Zarrindast, MR	1
Balbuena, L; Lodhi, RJ; Peters, EM	1

Reviews

9 review(s) available for bupropion and citalopram

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Second-generation antidepressants. The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3 Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine	1984
New approaches to the treatment of depression. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 4 Topics: Antidepressive Agents, Second-Generation; Brain; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Dopamine; Duloxetine Hydrochloride; Humans; Receptors, Dopamine; Receptors, GABA; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin; Thiophenes; Venlafaxine Hydrochloride	1996
Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:5 Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome	2006
Bupropion: a review of its use in the management of major depressive disorder. Drugs, 2008, Volume: 68, Issue:5 Topics: Antidepressive Agents, Second-Generation; Body Weight; Bupropion; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2008
Treatment-resistant depression and mortality after acute coronary syndrome. The American journal of psychiatry, 2009, Volume: 166, Issue:4 Topics: Acute Coronary Syndrome; Antidepressive Agents; Bupropion; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Myocardial Infarction; Personality Inventory; Psychometrics; Randomized Controlled Trials as Topic; Secondary Prevention; Survival Rate	2009
Meta-analysis: Second generation antidepressants and headache. Journal of affective disorders, 2018, 08-15, Volume: 236 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Citalopram; Depression; Double-Blind Method; Headache; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors	2018
Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials. Journal of affective disorders, 2019, 05-01, Volume: 250 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2019
Are all antidepressants the same? The consumer has a point. Psychological medicine, 2023, Volume: 53, Issue:9 Topics: Antidepressive Agents; Bupropion; Citalopram; Fluoxetine; Humans; Paroxetine; Sertraline; Venlafaxine Hydrochloride	2023

Trials

49 trial(s) available for bupropion and citalopram

Article	Year
The new generation antidepressants: promising innovations or disappointments? The Journal of clinical psychiatry, 1985, Volume: 46, Issue:10 Pt 2 Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine	1985
Second-generation antidepressants. The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3 Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine	1984
Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:3 Topics: Adult; Antidepressive Agents; Bupropion; Citalopram; Cohort Studies; Delayed-Action Preparations; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires	2004
Medication augmentation after the failure of SSRIs for depression. The New England journal of medicine, 2006, Mar-23, Volume: 354, Issue:12 Topics: Adult; Bupropion; Buspirone; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Failure	2006
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STARD report. The American journal of psychiatry, 2006, Volume: 163, Issue:7* Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Cross-Over Studies; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Mianserin; Middle Aged; Mirtazapine; Nortriptyline; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	2006
Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:5 Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome	2006
A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Attention; Bupropion; Chronic Disease; Citalopram; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Stress Disorders, Post-Traumatic; Tachycardia; Time Factors; Trazodone	2007
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STARD report. The American journal of psychiatry, 2007, Volume: 164, Issue:5* Topics: Adult; Ambulatory Care; Antidepressive Agents; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Over Studies; Cyclohexanols; Decision Trees; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride	2007
Bupropion in the treatment of outpatients with asthma and major depressive disorder. International journal of psychiatry in medicine, 2007, Volume: 37, Issue:1 Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Asthma; Bupropion; Citalopram; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Humans; Personality Inventory; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome	2007
A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder. Psychopharmacology bulletin, 2008, Volume: 41, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bupropion; Citalopram; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects	2008
What predicts attrition in second step medication treatments for depression?: a STARD Report. The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:4* Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Data Interpretation, Statistical; Depressive Disorder, Major; Drug Therapy, Combination; Female; Forecasting; Humans; Male; Middle Aged; Outpatients; Patient Dropouts; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Serotonin Receptor Agonists; Socioeconomic Factors; Young Adult	2009
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Archives of general psychiatry, 2008, Volume: 65, Issue:8 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Middle Aged; Personality Inventory; Primary Health Care; Prognosis; Retreatment; Secondary Prevention; Sertraline; Venlafaxine Hydrochloride	2008
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. Journal of psychiatric practice, 2008, Volume: 14, Issue:5 Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Young Adult	2008
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry research, 2009, Sep-30, Volume: 169, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroencephalography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Young Adult	2009
Does dual antidepressant therapy as initial treatment hasten and increase remission from depression? Journal of psychiatric practice, 2009, Volume: 15, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Male; Observer Variation; Pilot Projects; Remission Induction	2009
What did STARD teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatric services (Washington, D.C.), 2009, Volume: 60, Issue:11* Topics: Adolescent; Adult; Aged; Bupropion; Citalopram; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Primidone; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Pharmacogenetics studies in STARD: strengths, limitations, and results. Psychiatric services (Washington, D.C.), 2009, Volume: 60, Issue:11* Topics: Adult; Biomarkers; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride	2009
The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse. The American journal of drug and alcohol abuse, 2010, Volume: 36, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Female; Humans; Pregnancy; Pregnancy Complications; Pregnant Women; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance-Related Disorders; Treatment Outcome	2010
Developing thai economic model to study cost-effectiveness of switching to bupropion compared to combination with bupropion after the failure of an SSRI for major depressive disorder. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2010, Volume: 93 Suppl 6 Topics: Antidepressive Agents; Asian People; Bupropion; Citalopram; Cost-Benefit Analysis; Depressive Disorder, Major; Drug Costs; Drug Substitution; Drug Therapy, Combination; Humans; Models, Economic; Outpatients; Quality-Adjusted Life Years; Selective Serotonin Reuptake Inhibitors; Thailand; Treatment Outcome	2010
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. The American journal of psychiatry, 2011, Volume: 168, Issue:7 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Personality Inventory; Recurrence; Selective Serotonin Reuptake Inhibitors; Self Report; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2011
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2011, Volume: 12, Issue:7 Topics: Antidepressive Agents; Bupropion; Citalopram; Computer Simulation; Cost-Benefit Analysis; Depressive Disorder, Major; Genetic Testing; Humans; Meta-Analysis as Topic; Models, Psychological; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins	2011
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. Journal of affective disorders, 2011, Volume: 133, Issue:3 Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Depression; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2011
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2012, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicide; Treatment Outcome; Venlafaxine Hydrochloride	2012
Pharmacogenomic study of side-effects for antidepressant treatment options in STARD. Psychological medicine, 2012, Volume: 42, Issue:6* Topics: Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Factor Analysis, Statistical; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Linear Models; Linkage Disequilibrium; Membrane Proteins; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Sexual Dysfunction, Physiological; Treatment Outcome	2012
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:10 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Regression Analysis; Risk Factors; Self Report; Single-Blind Method; Suicidal Ideation; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2011
Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STARD trial. Acta psychiatrica Scandinavica, 2012, Volume: 125, Issue:4* Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Humans; Middle Aged; Quality of Life; Treatment Outcome	2012
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STARD. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:1* Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult	2012
[Six-month follow-up study of drug treatment for cannabis addiction: comparison study of four drugs]. Harefuah, 2011, Volume: 150, Issue:12 Topics: Adult; Bromazepam; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Follow-Up Studies; GABA Modulators; Humans; Marijuana Abuse; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome; Young Adult	2011
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. Depression and anxiety, 2012, Volume: 29, Issue:2 Topics: Adolescent; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Substance-Related Disorders; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2012
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:7 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prognosis; Prospective Studies; Psychometrics; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2012
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report. Psychological medicine, 2013, Volume: 43, Issue:5 Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Bupropion; Child Abuse; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Self Report; Severity of Illness Index; Single-Blind Method; Suicidal Ideation; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:1 Topics: Adult; Aged; Antidepressive Agents; Biomarkers; Bupropion; Citalopram; Depressive Disorder, Major; Drug Substitution; Drug Therapy, Combination; Electroencephalography; Female; Frontal Lobe; Humans; Male; Middle Aged; Personality Inventory; Predictive Value of Tests; Psychometrics; Secondary Prevention; Signal Processing, Computer-Assisted; Treatment Outcome; Young Adult	2013
Increase in work productivity of depressed individuals with improvement in depressive symptom severity. The American journal of psychiatry, 2013, Volume: 170, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Efficiency; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Work; Young Adult	2013
Auditory P3 in antidepressant pharmacotherapy treatment responders, non-responders and controls. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:11 Topics: Acoustic Stimulation; Adult; Antidepressive Agents; Bupropion; Case-Control Studies; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Event-Related Potentials, P300; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Psychomotor Performance; Sex Characteristics; Treatment Outcome	2013
Combination antidepressant therapy for major depressive disorder: speed and probability of remission. Journal of psychiatric research, 2014, Volume: 52 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents; Bupropion; Canada; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Treatment Outcome; United States; Young Adult	2014
Examining relations between alpha power as well as anterior cingulate cortex-localized theta activity and response to single or dual antidepressant pharmacotherapies. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:6 Topics: Adult; Alpha Rhythm; Antidepressive Agents, Second-Generation; Brain Mapping; Bupropion; Citalopram; Depression; Drug Therapy, Combination; Electroencephalography; Electrooculography; Female; Gyrus Cinguli; Humans; Male; Middle Aged; Theta Rhythm; Time Factors; Treatment Outcome	2014
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care. Journal of psychiatric practice, 2014, Volume: 20, Issue:2 Topics: Adult; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Placebos; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride	2014
Neurocognitive predictors of antidepressant clinical response. Journal of affective disorders, 2014, Volume: 166 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Case-Control Studies; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2014
The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: results from a randomized controlled trial. Psychiatry research, 2014, Dec-15, Volume: 220, Issue:1-2 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cognition; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Memory; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Treatment Outcome; Young Adult	2014
Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant? The Journal of clinical psychiatry, 2014, Volume: 75, Issue:9 Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Psychiatric Status Rating Scales; Psychological Tests; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2014
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report. Journal of affective disorders, 2015, Mar-15, Volume: 174 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outpatients; Predictive Value of Tests; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome; United States; Venlafaxine Hydrochloride	2015
Treatment of maternal depression in a medication clinical trial and its effect on children. The American journal of psychiatry, 2015, Volume: 172, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Child; Child of Impaired Parents; Citalopram; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mother-Child Relations; Mothers; Psychiatric Status Rating Scales; Treatment Outcome	2015
Cost-Effective Drug Switch Options After Unsuccessful Treatment With an SSRI for Depression. Psychiatric services (Washington, D.C.), 2017, 01-01, Volume: 68, Issue:1 Topics: Adult; Bupropion; Citalopram; Cost-Benefit Analysis; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2017
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial. Psychoneuroendocrinology, 2017, Volume: 78 Topics: Adult; Antidepressive Agents; Bupropion; C-Reactive Protein; Citalopram; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Remission Induction; Self Report; Treatment Outcome	2017
Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial. Journal of affective disorders, 2018, Volume: 234 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Body Mass Index; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Overweight; Patient Selection; Treatment Outcome; Venlafaxine Hydrochloride	2018
Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018, Volume: 43, Issue:11 Topics: Adult; Ambulatory Care; Antidepressive Agents; Bipolar Disorder; Bupropion; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outpatients; Self Report; Treatment Outcome; Venlafaxine Hydrochloride	2018
The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation. Depression and anxiety, 2019, Volume: 36, Issue:4 Topics: Adult; Aged; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Psychometrics; Risk Assessment; Self Report; Single-Blind Method; Suicidal Ideation; Venlafaxine Hydrochloride	2019
Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trial. Journal of affective disorders, 2019, 10-01, Volume: 257 Topics: Adult; Antidepressive Agents, Second-Generation; Asian People; Bupropion; China; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Least-Squares Analysis; Male; Middle Aged; Treatment Outcome; Young Adult	2019
Emotional blunting with bupropion and serotonin reuptake inhibitors in three randomized controlled trials for acute major depressive disorder. Journal of affective disorders, 2022, 12-01, Volume: 318 Topics: Adult; Antidepressive Agents; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2022

Other Studies

61 other study(ies) available for bupropion and citalopram

Article	Year
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Species independence in brain tissue binding using brain homogenates. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity	2011
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Evaluating the tolerability of the newer antidepressants. The Journal of nervous and mental disease, 1999, Volume: 187, Issue:2 Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride	1999
Depression, IV: STARD treatment trial for depression. The American journal of psychiatry, 2003, Volume: 160, Issue:2* Topics: Algorithms; Ambulatory Care; Antidepressive Agents; Bupropion; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic	2003
Antidepressant-like effects in various mice strains in the tail suspension test. Behavioural brain research, 2003, Aug-14, Volume: 143, Issue:2 Topics: Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Bupropion; Citalopram; Depression; Desipramine; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hindlimb Suspension; Imipramine; Male; Mice; Mice, Inbred Strains; Paroxetine; Selective Serotonin Reuptake Inhibitors; Species Specificity	2003
Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats. Psychopharmacology, 2005, Volume: 178, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Bupropion; Citalopram; Desipramine; Dextroamphetamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Norepinephrine; Piperazines; Rats; Rats, Wistar; Reflex, Startle; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Thiazoles	2005
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety. Consumer reports, 2004, Volume: 69, Issue:10 Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work	2004
Prenatal bupropion exposure enhances the cocaine reward and stress susceptibility in adult mice. The Chinese journal of physiology, 2005, Dec-31, Volume: 48, Issue:4 Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Citalopram; Cocaine; Conditioning, Operant; Female; Fluvoxamine; Male; Maternal Behavior; Mice; Mice, Inbred C57BL; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Stress, Physiological; Trazodone	2005
Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Sep-30, Volume: 30, Issue:7 Topics: Adult; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Dyskinesias; Humans; Male; Mental Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline	2006
Persistent sexual side effects after SSRI discontinuation. Psychotherapy and psychosomatics, 2006, Volume: 75, Issue:3 Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents	2006
Depression--augmentation or switch after initial SSRI treatment. The New England journal of medicine, 2006, Jun-15, Volume: 354, Issue:24 Topics: Bupropion; Buspirone; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Placebo Effect; Remission Induction; Research Design; Selective Serotonin Reuptake Inhibitors	2006
Psychopharmacology of smoking cessation in patients with mental illness. Journal of psychiatry & neuroscience : JPN, 2006, Volume: 31, Issue:5 Topics: Antidepressive Agents, Second-Generation; Anxiety; Arousal; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Male; Middle Aged; Smoking Cessation; Tobacco Use Disorder	2006
The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions. Drug safety, 2007, Volume: 30, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Second-Generation; Antimetabolites, Antineoplastic; Bupropion; Capecitabine; Citalopram; Clopidogrel; Cyclooxygenase 2 Inhibitors; Deoxycytidine; Drug Monitoring; Drug Prescriptions; Drug Utilization Review; Fluorouracil; Humans; Lactones; Meningococcal Vaccines; Platelet Aggregation Inhibitors; Primary Health Care; Scotland; Sulfones; Ticlopidine; Time Factors	2007
Augmentation strategies to increase antidepressant efficacy. The Journal of clinical psychiatry, 2007, Volume: 68 Suppl 10 Topics: Algorithms; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Drug Synergism; Humans; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline	2007
The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats. European journal of pharmacology, 2008, Mar-17, Volume: 582, Issue:1-3 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Drug Synergism; Imipramine; Injections, Intraperitoneal; Male; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulfonamides	2008
Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:7 Topics: Adult; Bupropion; Case-Control Studies; Citalopram; Cytokines; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors	2009
Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:1 Topics: Animals; Antidepressive Agents, Second-Generation; Autoreceptors; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Drug Synergism; Drug Therapy, Combination; Electrophysiology; Male; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors	2010
Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2 Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzamides; Benzyl Compounds; Bupropion; Citalopram; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Lorazepam	2009
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depression and anxiety, 2009, Volume: 26, Issue:8 Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Antidepressants as hydrobromide salts: are they a cause for concern? Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:4 Topics: Antidepressive Agents, Second-Generation; Bromides; Bupropion; Citalopram; Drug Interactions; Drug Labeling; Humans; Risk Assessment	2009
Effects of bupropion augmentation in escitalopram-resistant patients with major depressive disorder: an open-label, naturalistic study. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:7 Topics: Adult; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2009
Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats. Indian journal of experimental biology, 2010, Volume: 48, Issue:5 Topics: Acceleration; Amitriptyline; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain Injuries; Bupropion; Citalopram; Cyclohexanols; Exploratory Behavior; Fear; Male; Neuronal Plasticity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Wistar; Reflex, Startle; Serotonin; Social Behavior; Venlafaxine Hydrochloride	2010
Delayed, fatal cardiotoxicity associated with bupropion and citalopram overdose. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cardiotoxins; Citalopram; Delayed-Action Preparations; Depression; Drug Overdose; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sodium Channel Blockers; Suicide; Time Factors; Young Adult	2012
Reward responsiveness and fatigue in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2013, Volume: 19, Issue:2 Topics: Adult; Anxiety; Attention; Bupropion; Citalopram; Cognition; Depression; Disability Evaluation; Disorders of Excessive Somnolence; Dopamine Uptake Inhibitors; Fatigue; Female; Humans; Inhibition, Psychological; Male; Multiple Sclerosis; Neuropsychological Tests; Perception; Personality; Reaction Time; Recurrence; Reward; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2013
Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients. Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Platelet Count; Retrospective Studies; Venlafaxine Hydrochloride	2012
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial? The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride	2012
Tramadol precipitating serotonin syndrome in a patient on antidepressants. The Journal of neuropsychiatry and clinical neurosciences, 2012,Fall, Volume: 24, Issue:4 Topics: Analgesics, Opioid; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder; Drug Therapy, Combination; Humans; Male; Middle Aged; Musculoskeletal Pain; Serotonin Syndrome; Tramadol	2012
GPR39 up-regulation after selective antidepressants. Neurochemistry international, 2013, Volume: 62, Issue:7 Topics: Animals; Antidepressive Agents; Brain; Bupropion; Citalopram; Imipramine; Male; Mice; Morpholines; Reboxetine; Receptors, G-Protein-Coupled; Up-Regulation; Zinc	2013
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy? Psychopharmacology, 2014, Volume: 231, Issue:9 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Imipramine; Male; Morpholines; Norepinephrine; Rats, Sprague-Dawley; Reboxetine; Septal Nuclei; Time Factors	2014
Delirium caused by a drug-drug interaction between bupropion and risperidone. Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:1 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bipolar Disorder; Bupropion; Citalopram; Delirium; Drug Interactions; Drug Substitution; Drug Therapy, Combination; Humans; Male; Middle Aged; Risperidone; Treatment Outcome	2014
Animal model of methylphenidate's long-term memory-enhancing effects. Learning & memory (Cold Spring Harbor, N.Y.), 2014, Jan-16, Volume: 21, Issue:2 Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Bupropion; Central Nervous System Stimulants; Citalopram; Cocaine; Conditioning, Classical; Dose-Response Relationship, Drug; Fear; Female; Locomotion; Male; Maze Learning; Memory, Long-Term; Methylphenidate; Mice; Mice, Inbred C57BL; Nootropic Agents; Propylamines; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Space Perception	2014
An electronic health records study of long-term weight gain following antidepressant use. JAMA psychiatry, 2014, Volume: 71, Issue:8 Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Mass Index; Bupropion; Citalopram; Electronic Health Records; Female; Humans; Male; Middle Aged; New England; Nortriptyline; Prospective Studies; Weight Gain; Young Adult	2014
The development and validation of a turbulent flow-liquid chromatography-tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum. Clinical biochemistry, 2014, Volume: 47, Issue:15 Topics: Antidepressive Agents; Bupropion; Chromatography, Liquid; Citalopram; Drug Stability; Humans; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Solid Phase Extraction; Tandem Mass Spectrometry	2014
Development and validation of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous determination of bupropion, quetiapine and escitalopram in human plasma. Biomedical chromatography : BMC, 2015, Volume: 29, Issue:4 Topics: Antidepressive Agents; Bupropion; Chromatography, High Pressure Liquid; Citalopram; Humans; Quetiapine Fumarate; Tandem Mass Spectrometry	2015
Chronic but not acute antidepresant treatment alters serum zinc/copper ratio under pathological/zinc-deficient conditions in mice. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2014, Volume: 65, Issue:5 Topics: Animals; Antidepressive Agents; Bupropion; Citalopram; Copper; Depression; Disease Models, Animal; Imipramine; Male; Mice; Morpholines; Reboxetine; Sodium Chloride; Zinc	2014
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of affective disorders, 2015, Jul-15, Volume: 180 Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Effect of Treating Mothers' Depression on Children's Well-Being. The American journal of psychiatry, 2015, Volume: 172, Issue:5 Topics: Antidepressive Agents, Second-Generation; Bupropion; Child of Impaired Parents; Citalopram; Depression; Female; Humans; Male	2015
Hyponatraemia and confusion in a 70-year-old female when bupropion was added to dothiepin and escitalopram. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2015, Volume: 23, Issue:5 Topics: Aged; Antidepressive Agents; Bupropion; Citalopram; Confusion; Depressive Disorder, Treatment-Resistant; Dothiepin; Drug Therapy, Combination; Female; Humans; Hyponatremia	2015
Up-regulation of the GPR39 Zn2+-sensing receptor and CREB/BDNF/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient mice. Pharmacological reports : PR, 2015, Volume: 67, Issue:6 Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Bupropion; Citalopram; Cyclic AMP Response Element-Binding Protein; Down-Regulation; Drug Administration Schedule; Frontal Lobe; Imipramine; Male; Mice; Morpholines; Reboxetine; Receptor, trkB; Receptors, G-Protein-Coupled; Signal Transduction; Up-Regulation; Zinc	2015
Comparative study of the effects of bupropion and escitalopram on Internet gaming disorder. Psychiatry and clinical neurosciences, 2016, Volume: 70, Issue:11 Topics: Adolescent; Adult; Behavior, Addictive; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Humans; Internet; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Video Games; Young Adult	2016
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. Translational psychiatry, 2016, 09-13, Volume: 6, Issue:9 Topics: Adult; Antidepressive Agents; Bupropion; Chromosomes, Human, Pair 4; Circadian Rhythm; Citalopram; Depressive Disorder; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dopamine Uptake Inhibitors; Drug Resistance; Female; Genome-Wide Association Study; Humans; Male; Middle Aged; Neuronal Plasticity; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Surveys and Questionnaires; Treatment Outcome; Vascular Endothelial Growth Factor A	2016
Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach. JAMA psychiatry, 2017, Apr-01, Volume: 74, Issue:4 Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Bupropion; Citalopram; Cluster Analysis; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Randomized Controlled Trials as Topic; Sleep; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2017
Escitalopram induced thrombocytopenia reversed after shifting to bupropion in a depressive patient. The Australian and New Zealand journal of psychiatry, 2017, Volume: 51, Issue:10 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depressive Disorder; Humans; Male; Thrombocytopenia	2017
Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection. Brain, behavior, and immunity, 2017, Volume: 66 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Bupropion; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Inflammation; Interleukin-17; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Severity of Illness Index; T-Lymphocytes; Venlafaxine Hydrochloride	2017
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:4 Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride	2018
Second-generation anti-depressants and risk of new-onset seizures in the elderly. Clinical toxicology (Philadelphia, Pa.), 2018, Volume: 56, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Odds Ratio; Ontario; Population; Seizures	2018
Preliminary evidence of an association between increased cortical inhibition and reduced suicidal ideation in adolescents treated for major depression. Journal of affective disorders, 2019, 02-01, Volume: 244 Topics: Adolescent; Adolescent Behavior; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Motor Cortex; Neural Inhibition; Suicidal Ideation; Suicide Prevention; Transcranial Magnetic Stimulation	2019
Antidepressant Prescription Patterns in Bipolar Disorder: a Nationwide, Register-based Study in Korea. Journal of Korean medical science, 2018, Nov-12, Volume: 33, Issue:46 Topics: Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Bupropion; Citalopram; Female; Fluoxetine; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Prevalence; Registries; Republic of Korea	2018
Effects of monoamine uptake inhibitors on pain-related depression of nesting in mice. Behavioural pharmacology, 2019, Volume: 30, Issue:6 Topics: Analgesics, Opioid; Animals; Behavior, Animal; Bupropion; Citalopram; Conditioning, Operant; Dopamine Uptake Inhibitors; Fluoxetine; Ketoprofen; Lactic Acid; Male; Mice; Mice, Inbred ICR; Milnacipran; Nesting Behavior; Pain; Receptors, Opioid, kappa; Self Stimulation	2019
Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity. The American journal of psychiatry, 2019, 05-01, Volume: 176, Issue:5 Topics: Adult; Ambulatory Care; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Female; Humans; Irritable Mood; Logistic Models; Male; Middle Aged; Mirtazapine; Prognosis; Randomized Controlled Trials as Topic; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2019
Drug testing complementary metal-oxide-semiconductor chip reveals drug modulation of transmitter release for potential therapeutic applications. Journal of neurochemistry, 2019, Volume: 151, Issue:1 Topics: Animals; Bupropion; Cattle; Cells, Cultured; Central Nervous System Agents; Chromaffin Cells; Citalopram; Drug Discovery; High-Throughput Screening Assays; Neurotransmitter Agents; Semiconductors	2019
Using prefrontal and midline right frontal EEG-derived theta cordance and depressive symptoms to predict the differential response or remission to antidepressant treatment in major depressive disorder. Psychiatry research. Neuroimaging, 2020, 08-30, Volume: 302 Topics: Adult; Antidepressive Agents; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Electroencephalography; Female; Frontal Lobe; Humans; Male; Middle Aged; Prefrontal Cortex; Prognosis; Remission Induction; Theta Rhythm; Treatment Outcome	2020
27-year-old woman • postpartum seizures • PTSD • history of depression • Dx? The Journal of family practice, 2021, Volume: 70, Issue:6 Topics: Adult; Antidepressive Agents; Bupropion; Citalopram; Depression, Postpartum; Female; Humans; Seizures; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome	2021
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study. Pharmacotherapy, 2021, Volume: 41, Issue:11 Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2021
Comparison of the effect of citalopram, bupropion, sertraline, and tricyclic antidepressants on QTc: A cross-sectional study. Journal of affective disorders, 2022, 01-01, Volume: 296 Topics: Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	2022
Isobolographic analysis of the antidepressant interaction in two-drug combinations of citalopram, bupropion, and scopolamine in mice. Naunyn-Schmiedeberg's archives of pharmacology, 2022, Volume: 395, Issue:7 Topics: Animals; Antidepressive Agents; Bupropion; Citalopram; Drug Combinations; Humans; Male; Mice; Mice, Inbred Strains; Scopolamine	2022